Academic Press Nanoparticle Therapeutics: Production Technologies, Types of Nanoparticles, and Regulatory Aspects

Nanoparticle therapeutics: Production Technologies, Types of Nanoparticles, and Regulatory Aspects employs unique principles for applications in cell-based therapeutics, diagnostics and mechanistics for the study of organ physiology, disease etiology and drug screening of advanced nanoparticles and nanomaterials. The book focuses on the extrapolation of bioengineering tools in the domain of nanotechnology and nanoparticles therapeutics, fabrication, characterization and drug delivery aspects. It acquaints scientists and researchers on the experiential and experimental aspects of nanoparticles and nanotechnology to equip their rational application in various fields, especially in differential diagnoses and in the treatment of diverse diseased states. This complete resource provides a holistic understanding of the principle behind formation, characterization, applications, regulations and toxicity of nanoparticles employing myriad principles of nanotechnology. Investigators, pharmaceutical researchers, and advanced students working on technology advancement in the areas of designing targeted therapies, nanoscale imaging systems and diagnostic modalities in human diseases where nanoparticles can be used as a critical tool for technology advancement in drug delivery systems will find this book useful. Review Examines vital aspects of diverse nanoparticles, providing a next generation diagnostics and therapeutics About the Author Dr. Prashant Kesharwani is Assistant Professor of Pharmaceutics at the School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. He has published more than 150 articles in well reputed international journals and edited 10 international books. Dr. Kesharwani has received several awards, including the ‘Ramanujan Fellowship, DST, India-2017’, ‘Excellence Research Award 2014’, ‘Young Innovator Award (Gold medal) 2012’, ‘International Travel Award/Grant from DST (New Delhi) and INSA (CCSTDS, Chennai) 2012’, as well as receiving an ICMR Senior Research Fellowship (PhD) and AICTE Junior Research Fellowship (M. Pharm.). He has presented invited talks and presentations at prestigious conferences, supervised students/junior researchers, and actively participated in outreach and scientific dissemination for the service of the wider community. Dr. Kesharwani’s current research is focused on the development of nano-engineered drug delivery systems for various diseases. Prof Kamalinder K Singh is Professor of Pharmaceutical Technology & Drug Delivery and Research Lead at the School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom and heads the Nanomedicine and Innovative technologies research group within the Faculty of Clinical and Biomedical Sciences and is Healthcare Lead for UCLan Centre of Smarts Materials. With more than 35 years’ experience in academia, Prof Singh has contributed significantly to the field of pharmaceutical technology, drug delivery and nanomedicine through authorship of over 80 research articles, 18 patents, 12 book chapters and 60 monographs. Her pioneering research has led to development of many biocompatible nanoparticle-based platform technologies exploiting to deliver drugs across various biological barriers with application to human health and diseases. Prof Singh serves on International Steering Committee for ‘Handbook of Pharmaceutical Excipients’, joint publication by AAPS, Pharmaceutical Press, and Royal Pharmaceutical Society, Great Britain. She has provided leadership to 35 major funded research projects and is currently managing several research projects funded by National Institute of Health, Academy of Medical Sciences, British Council and UK Foreign Commonwealth and Development Office. She has supervised 30 ECRs and delivered more than 70 keynotes and invited talks at prestigious forums around the globe.